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Abstract
Cycling is a not weight-bearing activity and is known to induce bone resorption. Stage races are really strenuous endurance
performances affecting the energy homeostasis. The recently highlighted link, in the co-regulation of bone and energy
metabolism, demonstrates a central role for the equilibrium between carboxylated and undercarboxylated forms of
osteocalcin. Aim of this study was to understand the acute physiological responses to a cycling stage race in terms of bone
turnover and energy metabolism and the possible co-regulative mechanisms underlying their relationship. We studied nine
professional cyclists engaged in 2011 Giro d’Italia stage race. Pre-analytical and analytical phases tightly followed academic
and anti-doping authority’s recommendations. Bone and energy metabolism markers (bone alkaline phosphatase, tartrate-
resistant acid phosphatase 5b, total and undercarboxylated osteocalcin, leptin and adiponectin) and related hormones
(cortisol and testosterone) were measured, by Sandwich Enzyme Immunoassays, at days -1 (pre-race), 12 and 22 during the
race. The power output and the energy expenditure (mean and accumulated) were derived and correlated with the
biochemical indexes. During the race, bone metabolism showed that an unbalance in behalf of resorption, which is
enhanced, occurred along with a relative increase in the concentration of the undercarboxylated form of osteocalcin that
was indirectly related to the enhanced energy expenditure, through adipokines modifications, with leptin decrease (high
energy consumption) and adiponectin increase (optimization of energy expenditure). The exertion due to heavy effort
induced a decrease of cortisol, while testosterone levels resulted unchanged. In conclusion, during a 3-weeks stage race,
bone metabolism is pushed towards resorption. A possible relationship between the bone and the energy metabolisms is
suggested by the relative correlations among absolute and relative concentrations trends of undercarboxylated OC,
adipokines concentrations, BMI, fat mass (%), power output and the derived energy expenditure.
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Introduction
Professional cycling 3-weeks stage races such as Tour de France,
Vuelta a Espan˜a and Giro d’Italia, very popular sport events, could be
included among the most strenuous athletic performances [1].
These races last 21–22 days with more than 3000 km covered and
only one or two days of rest; athletes are submitted to very intense
metabolic effort, combining aerobic and anaerobic metabolism,
particularly during mountain stages and time trials [2,3,4]. Thus,
studies concerning the metabolic changes occurring during these
competitions are of particular interest for describing the bio-
chemical pathways orchestrating the energy expenditure required
to perform the mechanical work, as highlighted by previous studies
on endurance athletes [5,6].
Although, papers concerning hormonal, haematological and
biochemical changes during cycling races are available [7,8], the
link between bone and energy in cycling has never been
investigated.
The modification of the hormonal profile during the Vuelta
a Espan˜a was described in detail [2,7,9]. Morning serum
concentrations of testosterone, FSH, LH and cortisol, in nine
cyclists during the Vuelta 1999, measured before the race (at the
end of the first, the second and the third week of competition)
showed no variations in gonadotropins, and a decrease in cortisol
and testosterone as a result of long duration and intense exercise
[2]. Interestingly, thyroid hormones, which are known to be
involved in adaptation of an organism to physical exercise [9],
were modified during a Vuelta. Hormones were measured in 16
cyclists before the race and at the end of each of the three weeks
of competition: free 3,5,39-triiodothyronine, total and free-
thyroxine significantly increased during the last part of the race,
while TSH and total 3,5,39-triiodothyronine remained un-
changed. The increase in thyroid hormones might be due to
haemoconcentration or to the release of thyroid hormone-
transporting proteins. These effects could be also related to an
impaired peripheral conversion of thyroxine to 3,5,39-triiodothy-
ronine [9], possibly brought by cortisol increase that is in turn
induced by leptin decrease [10], as a result of an energy
unbalance. This response is typical of the hardest part of the
race, when mountain stages, requiring high energy expenditure,
are common [2,11]. The intensity and the duration of the
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exercise during 3-weeks stage races induce a rise of insulin
growth factor I concentrations during the first week, and, after
an adaptation, its stabilization after three weeks. This parameter
is linked to nutritional status and to both insulin and growth
hormone production and release [7].
Bone metabolism, especially bone formation, is known to be
enhanced by exercise. Physical activity is indeed recommended for
assuring correct bone density and homeostasis, and to prevent
bone mineral depauperation. Bone mineral density (BMD),
assessed in athletes practicing different sports, showed general
positive effect, but with wide differences between disciplines,
especially when considering distinct bone districts, genders and
weight-bearing exercise level. On the other hand, no univocal data
have been obtained from bone metabolism markers, although it is
evident that, at least long-lasting loads increase the circulating
levels of formation markers [12,13].
Cycling is characterized by a low level of skeletal load, with the
training specifically based on the not-weight-bearing bike riding
performed across the whole year. As a consequence, cyclists have
lower BMD than runners [14] and age-matched controls [15];
furthermore, bone health status in adolescent cyclists is affected by
the heavy training and the exercise in absence of load [16].
Bone markers were never studied in long-term cycling
performances. Therefore, no data about the possible bone
metabolism changes during a high-demanding 3-weeks stage race
exist. Noteworthy, a modern approach to bone function is
claiming its active role in regulating energy metabolism [17].
The regulation of osteoblasts and osteoclasts activity has recently
been integrated into an endocrine perspective, which includes
a consistent link with energy metabolism and sympathetic nervous
system. The endocrine function of the bone is exerted through the
release of a series of hormones and, among them, osteocalcin
(OC), a molecule with a role in local bone physiology, but also able
to regulate fat and glucose metabolism, insulin secretion and
pancreatic b cells proliferation; moreover, in adipocyte, OC
induces the release of adiponectin which, in turn, reduces insulin
resistance [12,17,18]. OC is a 5.8 kDa, hydroxyapatite-binding,
protein exclusively synthesized by osteoblasts, odontoblasts and
hypertrophic chondrocytes. It possesses 3 vitamin-K dependent, c-
carboxyglutamic acid residues (Gla-OC), which are responsible for
the calcium binding properties of the protein. There are some
post-transcriptional forms of OC. In energy metabolism pathway,
it is of particular interest the undercarboxylated form (Glu-OC)
which could be directly released, by osteoblasts, in balance with
the carboxylated form [17,18], or released from the main OC
molecule, when the bone environment is acidified by acid
phosphatase activity, expression of activation of osteoclasts [19].
Circulating Glu-OC acts on insulin-sensitive tissues and pancreatic
b cells [18].
The control of OC secretion is assured by sympathetic tone,
which is in turn controlled by leptin, an adipocyte-derived
hormone, which can regulate osteoblasts: its action is mediated
through two different neural pathways. Leptin concentrations are
not influenced by short exercise, but are decreased by long-term
exercise or by exercise with high energy expenditure; adiponec-
tin, instead, presents a delayed increase. In general, long-term
exercise could decrease leptin and increase adiponectin. Adipo-
nectin concentrations are negatively related with body fat, fasting
plasma insulin and oral glucose tolerance and positively related
with glucose disposal. No data concerning leptin and adiponectin
concentrations at rest and after exercise in cyclists exist [20].
Leptin and adiponectin correlate positively and negatively with
fat mass, respectively in normal and overweight subjects. Among
professional athletes, cyclists appear to have the lowest body mass
index (BMI), fat percentage and adipokines concentrations,
especially during long-term training and competition. BMI in
cyclists could significantly change during a 3-weeks stage race
[11]: this finding should be taken into account for interpreting
metabolism modifications.
The regulation of energy metabolism in cyclists during a high-
demanding and long-lasting race is crucial for maintaining
a sufficient level of performance for three weeks. This study is
aimed to study bone metabolism markers, adipokines and
hormones involved in the loop of energy metabolism regulation
in professional cyclists who competed in the 2011 Giro d’Italia.
The choice of cyclists involved in a 3-week stage race, in order to
study the integrative physiology of bone and energy metabolism,
was derived from the evidence of peculiar body composition and
accelerated bone turnover of these athletes associated with the
extreme energy demands necessary to carry out the race.
Materials and Methods
Ethics Statement
The study was approved by the Reference Ethical Committee
(ASL Milano 1). The athletes involved in this study have given
written consent for sample collection and data analysis. Clinical
investigations were conducted according to the principles
expressed in the Declaration of Helsinki.
Subjects
Nine professional cyclists belonging to the Liquigas-Cannondale
team were recruited. They were involved in the Giro d’Italia 2011
and followed across the race, from May 8th to May 29th.
Athletes covered 3524.5 km and the mean speed was 35.6 km/h.
The route characteristics are reported in Table 1.
Mean athletes’ age was 26.762.5 years. Weight and height were
measured in the morning before the stage in fasting conditions and
body mass index (BMI) was calculated as weight/(height)2;
anthropometrical parameters are reported in Table 2.
No drugs or supplements influencing the iron metabolism were
taken by athletes; only non-steroidal anti-inflammatory drugs and
antibiotics were administered where needed. The Giro 2011 was
a ‘‘no-needle’’ race: therapies and drugs were allowed only for
evident diseases. Diet was strictly controlled by team physicians
and was composed by a 45% of carbohydrates, 36% of proteins
and 19% of lipids. The caloric intake was balanced on the base of
the energy expenditure; it was set at 6000 kcal/day and kept for
the whole study.
Blood drawings were performed on the day before the start
(day -1), and on days 12 and 22 of the race (Table 1).
At day -1 athletes performed 3 h of light training at 55%
VO2max including a short bout (30 min) of medium-high levels
sub-threshold commitment at 60% VO2max. The diet on day -1
had the same composition of that carried out during the race.
Power Output and Net Energy Expenditure
Measurements
The individual power output was measured for each stage,
through the power sensor PowerMeterTM (SRM GmbH, Ju¨lich,
Germany) integrated within the bike pedal (sensitivity 62%), as
previously described [21]. Briefly, the PowerMeterTM utilizes 8
strain gauges on 16 grids, within a Wheatstone’s bridge: when the
force is applied on the pedals the resistance to the transmission
impresses a pressure on the measuring bridge. The pressure
intensity proportionally modifies the strain gauge length that is
translated in a change of the electrical resistance and thus in
a proportional variation of the output frequency. The instanta-
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neous torque (t), calculated as the output frequency subtracted of
the basal frequency, and the instantaneous angular velocity (v) are
related to the power output (P) as follow:
P Wð Þ~t Nmð Þ.v rad=sð Þ
The PowerMeterTM automatically derived the instantaneous
energy expenditure (kcal) from the instantaneous power output
by applying the following unit conversion equivalence:
W~2:39.10{4kcal.s{1
The total energy expenditure is given by the sum of the
instantaneous expenditures.
Blood Drawings
Pre-analytical warnings were strictly followed [22] to avoid any
possible factor affecting the analytical phase [23]. Particularly,
International Cyclist Union (UCI) and World Anti-Doping
Agency (WADA) guidelines for collection and transport of
specimens were followed [24].
Blood was drawn between 0800 and 1000 h in fasting subjects
resting in bed ten minutes after their awaking. Evacuated tubes
(BD Vacutainer Systems, Becton–Dickinson, Franklin Lakes, NJ,
USA) were used for analytes measurement (BD K2EDTA 3.5 mL
and 7.0 mL plain tubes, BD SSTII Advance). Immediately after
drawing, tubes were inverted ten times and stored in a sealed box
at 4uC. Controlled temperature was assured during transportation:
a specific tag (Libero Ti1, Elpro, Buchs, Switzerland) was used for
temperature measurement and recording. Samples were trans-
ported by car or by both train and car: the time elapsed from
drawing to laboratory was 1 h 30 min at day -1, 7 h 50 min at day
12, and 1 h 30 min at day 22. The differences in delay were due to
the sampling performed in places at different distances from the
laboratory. Such delays do not affect the analytical output for the
measured parameters [25].
The K2EDTA-anticoagulated blood was homogenized for
15 min prior to be analyzed, as recommended by UCI and
WADA [24].
Official anti-doping controls were performed, by antidoping
agencies, prior the start of the race (day -3) and during the final
phases (day 20); moreover, one of the recruited subjects was
submitted to an additional check at day 5 (Table 2).
Table 1. Characteristics of the route.
Day Stage Stage Lenght (km) Level Difference (m) Kind of Stage Blood drawing
23 / / / / Official Antidoping
22 / / / /
21 / / / / Study
1 1 19.3 96 Time Trial
2 2 244.0 780 Flat
3 3 173.0 2340 Flat
4 4 216.0 2779 Medium Mountain
5 5 191.0 3637 Medium Mountain Official Antidoping
6 6 216.0 3200 Flat
7 7 110.0 2796 Medium Mountain
8 8 217.0 912 Flat
9 9 169.0 5412 Mountain
10 Rest / / /
11 10 159.0 882 Flat
12 11 144.0 3097 Medium Mountain Study
13 12 184.0 463 Flat
14 13 167.0 4664 Mountain
15 14 210.0 6643 Mountain
16 15 229.0 9490 Mountain
17 Rest / / /
18 16 12.7 756 Time Trial
19 17 230.0 5336 Medium Mountain
20 18 151.0 1949 Flat Official Antidoping
21 19 209.0 3569 Mountain
22 20 242.0 3464 Mountain Study
23 21 31.5 67 Time Trial
In the Table are reported the correspondence between day, length (km), level difference (m) of each stage along with the kind of stage and the blood sampling
performed for this study and the blood sampling for official anti-doping testing.
doi:10.1371/journal.pone.0042077.t001
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Renal Function
Renal function was monitored by using creatinine and cystatin
C. Estimated glomerular filtration rate (eGFR) was calculated by
different equations based on these two parameters [26].
Analytes Measurement
Total Osteocalcin (Gla-OC) and undercarboxylated Osteocal-
cin (Glu-OC) were measured, in plasma, by Sandwich Enzyme
Immunoassays (EIA - Takara Bio Inc., Otsu, Shiga, Japan) using
specific monoclonal antibodies directed against the different forms
of OC, following the manufacturer specifications. The specificity
was 0.5 ng/mL for the Gla-OC assay kit and 0.25 ng/mL for the
Glu-OC assay kit, while the within-run and between-run
coefficients of variation (CV) were 4.8% and 2.4% for Gla-OC
and 6.7% and 9.9% for Glu-OC.
The percentage ratio of Glu-OC relative to the total OC was
calculated as:
Glu{OC %ð Þ~ Glu{OC=TotalOCð Þ.100
Bone-specific alkaline phosphatase (BAP) and Tartrate-resistant
Acid Phosphatase 5b (TRAP5b) activities were measured in serum
by immunocapture methods (Quidel Corporation, San Diego, CA,
USA) based on the conversion of the uncolored p-nitrophenylpho-
sphate in its yellowish-colored dephosphorylated form, the p-
nitrophenol in alkaline or acidic environment, respectively. The
sensitivity of BAP assay kit was 0.7 U/L and CVs were 5.8% and
7.6%. The sensitivity of TRAP5b was 0.2 U/L and CVs were
2.2% and 3.0%.
Adiponectin and leptin concentrations were measured in serum
by ELISA using specific capture monoclonal antibodies (R&D
Systems Inc., Minneapolis, MN, USA). Briefly, according to
manufacturer specifications, microplates were coated for 18 hours
with the capture antibodies (2.0 mg/ml for adiponectin and
4.0 mg/ml for leptin), washed 3 times with 0.05% Tween 20 in
phosphate buffered saline, pH 7.3, and blocked for 1 hour with
1% bovine serum albumin in phosphate buffer, pH 7.3. Following
3 washes, diluted samples (1:10) in 1% bovine serum albumin in
phosphate buffer, pH 7.3, were added in duplicates and incubated
for 2 hours. The horseradish peroxidase-conjugated polyclonal
detection antibodies (2.0 mg/ml for adiponectin and 12.5 ng/mL
for leptin) (R&D Systems Inc., Minneapolis, MN, USA) were
added and incubated for 2 hours. Following 3 washes, a solution of
1:1 H2O2-Tetramethylbenzidine was added for 20 min and then
the reaction was stopped with 1N H2SO4. All steps were
performed at RT. The absorbance were read at l=450 nm
(VICTORTM X3, Perkin Elmer, Waltham, MA, USA). The
analytes concentrations in samples were calculated against their
respective standard curves. All samples and standards were
evaluated in duplicate.
Serum cortisol and testosterone concentrations were tested on
a Bayer Elecsys 2010 (Bayer AG, Leverkusen, Germany).
Sensitivities were 0.018 mg/dL for cortisol and 0.025 ng/mL for
testosterone, while CVs were 2.8% and 3.4%, respectively.
During the study the analyzers were regularly calibrated and
controlled by both internal and external quality control schemes;
moreover, all analytes were assayed in a single batch and by the
same technician to limit analytical variability.
Statistical Analysis
Statistical analysis was performed by GraphPad Prism v5.0
software (GraphPad Software Inc., LaJolla, CA, USA). All values
in the descriptive analysis are expressed as the mean 6 SD.
Normal distribution of values were assayed by Kolmogorov-
Smirnov normality test, while one-way Analysis of Variance
(ANOVA) for repeated measures, with the Bonferroni’s correction,
was used to compare data over time. Paired comparisons were
performed by two-tailed t test. In the case of not normally
distributed values, repeated measures were compared with the
Kruskal-Wallis test with the Dunns’ correction. Correlation
analysis was performed by the two-tailed Pearson correlation test
(Spearman’s test for not normally distributed values); the same test
was conducted to evaluate the correlation between the trends of
these parameters across the time-points. The significance level was
set at 0.05.
Results
Anthropometric and Power Measurements
Body weight significantly decreased in the second phase of the
race, with the 22nd day significantly differed from day -1 and day
12 (Table 2). Consequently, the BMI at day 22 (20.461.06) was
significantly lower than those calculated for day -1 (20.961.27,
p,0.001) and day 12 (20.861.14, p,0.001).
Table 2. Anthropometric and power-related measurements across the stage race.
Parameters day -1 day 12 day 22 P-value
Height (m) 1.8260.05 / / /
Weight (kg) 69.165.24a 68.964.94a 67.465.06b ,0.05
Mean power output (W) / 214.3614.96a 256.2614.63b ,0.001
Mean power output/Weight (W/kg) / 3.160.17 3.760.16 ,0.001
Accumulated power output (W) / 1929.06134,60a 2305,56131,69b ,0.001
Accumulated power output/Weight (W/kg) / 27.961.56 33.461.43 ,0.001
Mean net energy expenditure (kcal) 2213.16156.01a 3401.56249.41b 3755.96239.96c ,0.001
Accumulated net energy expenditure (kcal) 2213.16156.01a 30613.462244.66b 33803.062159.62c ,0.001
In the Table are reported the results of the measurements at the same time-points of blood sampling, with the exception of the height that is reported only for day -1.
Mean power output and accumulated power output, as both raw data and corrected for body weight, refer to the mean or the sum, respectively, of the consecutive
measurements relative to the period preceding the blood sampling. The same applies to mean net energy expenditure and accumulated net energy expenditure for
whom the rest values (day -1) correspond to the basal metabolic rate. Measurements are expressed as mean6SD and values bearing different letters in apex are
significantly different (p,0.05).
doi:10.1371/journal.pone.0042077.t002
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To characterize the metabolic effort in which the athletes are
involved, the power output and the net energetic expenditure were
derived. Values are reported in Table 2. The mean of all the
measurements relative to the first half of the race was significantly
lower than those of the second phase (p,0.001) as well as the sum
of all the measurement (accumulated power output) until day 11
compared with those accumulated until day 21 (p,0.001). Even
for what concern the net caloric expenditure, an increase was
evident throughout the race with significant differences among the
basal value, the mean and the accumulated expenditures until the
12th and the 22nd day.
Both the mean and the accumulated power outputs strongly
correlated with the accumulated and the mean net energy
expenditures (r = 0.95, p,0.001), and when they are corrected
for body weight, this relationship is approximate to perfect fit
(r = 0.99, p,0.001).
Renal Function
No significant differences were reported on the serum param-
eters and also in glomerular filtration rate estimated using the
Chronic Kidney Disease-Epidemiology Collaboration (CKD-EPI)
creatinine equation, as previously reported [26].
Bone Metabolism Markers
The trend of the bone metabolic markers is illustrated in
Figure 1. BAP was unchanged (Figure 1A), whilst TRAP5b
increased in the final part of the race respect to day -1 (p,0.01)
(Figure 1B).
To give a numerical evaluation of the difference in metabolic
activity of osteoblast and osteoclast, the ratio between the main
metabolic indexes of these cells (BAP/TRAP5b) was calculated.
The BAP/TRAP5b ratio significantly decreased from 8.362.51 at
day -1 to 7.462.33 at day 12 (p,0.05) and to 6.562.10 at day 22
(p,0.001).
A fair correlation was found between BAP and TRAP5b trends
(r = 0.44, p,0.05), while no correlation was found with the indexes
of energetic expenditure and power output.
Osteocalcin
The data of total OC and Glu-OC are illustrated in Figure 2.
Total OC decreased along the race (p,0.01 between day -1 and
day 12, p,0.05 between day -1 and day 22) (Figure 2A). Absolute
Glu-OC concentrations, at the contrary, were unchanged during
the race, but they showed a higher inter-individual variability
(Figure 2B).
The relative concentration of Glu-OC, i.e. the percentage of
total OC represented by Glu-OC, increased in the first part of race
(p,0.01) (Figure 2C).
Moderate to good correlations were found between TRAP5b
and total OC (r = 0.50, p,0.05), total OC and Glu-OC (r = 0.51,
p,0.05), Glu-OC and Glu-OC percentage (r = 0.80, p,0.001);
total OC fairly correlated with BAP/TRAP5b ratio (r = 0.37,
p,0.05). Total OC correlated with mean and accumulated power
outputs in a fair indirect manner (r =20.44, p,0.05 for raw data,
and r =20.46, p,0.05 for weight corrected power outputs) and
inversely with accumulated and mean net energy expenditures
(r =20.44, p,0.05).
Energy Metabolism Markers
Adipokines behavior during the race is shown in Figure 3. While
adiponectin constantly rose (p,0.001 between day -1 and day 22,
p,0.01 between day 12 and day 22) (Figure 3A), leptin steadily
decreased (p,0.05 between day -1 and day 12; p,0.01 between
day -1 and day 22) (Figure 3B).
Adiponectin and leptin were inversely fairly related (r =20.41,
p,0.05) and they fairly correlated with the BAP/TRAP5b index
(r = 0.30, p,0.05; r = 0.32, p,0.05, respectively), while only
adiponectin correlated with total OC in a fair indirect manner
(r = 0.37, p,0.05). Adiponectin, but not leptin, and fairly
correlated with Glu-OC (r = 0.30, p,0.05). Of note, the GluOC
(%) directly fairly correlated with BMI (r = 0.41, p,0.05) and the
fat mass percentage (r = 0.48, p,0.05), while absolute concentra-
tions of GluOC fairly correlated with fat mass percentage (r = 0.45,
p,0.05). Parallel, adiponectin, but not leptin, showed a direct
moderate correlation with BMI (r = 0.51, p,0.001).
For what concern the mean and the accumulated power outputs
they both equally correlated with the energy markers adiponectin
(r = 0.44, p,0.05) and, inversely, but more strongly, with leptin
(r =20.72, p,0.001). These correlations were kept when the
power outputs were adjusted on body mass.
The energy expenditures indexes showed a good correlation,
directly, with adiponectin (r = 0.51, p,0.01) and inversely with
leptin (r =20.69, p,0.001).
Figure 1. Modification of serum bone markers activity over the
race. The Figure shows the trends of serum BAP (panel A) and serum
TRAP5b (panel B) over the stage race. ** indicates a significant variation
(p,0.01).
doi:10.1371/journal.pone.0042077.g001
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Hormones
Testosterone concentration was unchanged during the race
(Figure 4A), whereas cortisol concentration at day 22 were
decreased in respect to day -1 (p,0.01) (Figure 4B).
No differences in the ratio cortisol/testosterone were observed
throughout the study; the values attested at 51.5616.57 at day -1,
44.6614.86 at day 12 and 48.3615.25 at day 22.
Cortisol was directly fairly related with GlaOC (r = 0.41,
p,0.05) and moderately with leptin (r = 0.55, p,0.01) and body
mass (r = 0.56, p,0.01). Testosterone was directly moderately
correlated with body weight (r = 0.56, p,0.01). Moreover,
cortisol, but neither testosterone nor cortisol/testosterone, was
inversely related with accumulated and mean power outputs, both
as raw data (r =20.45, p,0.05) and corrected for weight
(r =20.47, p,0.05). Finally accumulated and mean net energy
expenditures were fairly inversely related to cortisol levels
(r =20.44, p,0.05).
Discussion
Three-weeks cycling stage races represent unique and paradig-
matic situations of long and strenuous daily competition [27,28]
and they represent ideal models for investigating the homeostatic
responses to strenuous and continuative workload. Cycling is one
of hardest sport discipline, owing to high demanding training and
competition, long-lasting season, high level of competition and
high selection within athletes that results in only about 800
professionals in the world. The 3-weeks stage races represent the
highest level of fatigue [28], possibly affecting the athletes’ health.
A recent knowledge in endocrinology suggests a fundamental
role of bone in energy metabolism. Bone is not a passive tissue but
it is able to secrete hormones, and, among them OC, which act on
pancreatic cells to regulate insulin and, consequently, glucose
Figure 2. Modification of plasma osteocalcin levels and relative
concentration of Glu-OC over the race. The Figure shows the
trends of plasma total OC (panel A), plasma Glu-OC (panel B) and
relative percentage concentration of Glu-OC (panel C) over the stage
race. ** and * indicate significant variations (p,0.01 and p,0.05,
respectively).
doi:10.1371/journal.pone.0042077.g002
Figure 3. Modification of adipokines levels over the race. The
Figure shows the trends of serum adiponectin (panel A) and serum
leptin (panel B) over the stage race. ***, ** and * indicate significant
variations (p,0.001, p,0.01 and p,0.05, respectively).
doi:10.1371/journal.pone.0042077.g003
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disposal and utilization in peripheral tissues, particularly in skeletal
and cardiac muscles [17,29]. Cycling is known to affect bone
metabolism [14], even in young [16]: previous reports suggest that
cycling could be dangerous for bone homeostasis and, conse-
quently, it could affect all the bony-regulated functions. An
unbalance between bone formation and resorption does not
represent only a local issue but it could have systemic impacts.
Although the effects on bone metabolism are exerted during
long periods of time, the strong effort of a 3-weeks stage race could
be sufficient to induce valuable modifications. The stimulation of
osteoblastic and/or osteoclastic function is dependent on exercise,
but the response appears to be not immediate in experimental
studies based on training periods. However, in professional
athletes this delay should not be considered: the skeleton is
continuously loaded/unloaded and stimulated [12]. At this
purpose, it is important to underline that the Giro occurs in the
month of May, after three months of training and two of training
and competition.
In this study we tried to define a correlation among the indexes
of bone metabolism, those of energy utilization and the
measurement of effort within the context of one of the hardest
cycling races.
The metabolic effort was characterized through the measure-
ment of the power output and they were comparable with those
previously reported for a six-stage road stage and the Tour de
France [30,31]. Only Vogt, in 2008 [32], recorded a 29% higher
power output, but the data were referred to only the ascents of the
Tour. To better correlate the indexes of metabolic effort with the
physiological response, the power output (raw and corrected for
body weight) and the net energy expenditure were calculated as
the mean and the accumulated values relative to the period
preceding the blood sampling (Table 2).
For what concern the bone metabolism, BAP activity remained
stable (Figure 1A), testifying that osteoblast metabolism, and thus
bone formation, are preserved during such a strenuous exercise.
BAP activity decreased the day after an ultramarathon of 245 km
and then recovered pre-race values after 3 and 5 days [33].
Throughout the training year BAP activity was reported to
decrease in professional triathletes [34] and to increase in alpine
skiers [13]. Thus, BAP activity is modified in long-term periods in
athletes: a stage race could be too short for evidencing
modifications or even, cyclists could have specific stability of bone
formation parameters, as deducted from the narrow inter-
individual variability in these athletes; however, data on this
specific topic are lacking.
The bone resorption appear to be stimulated during the race as
witnessed by the increase in TRAP5b activity more evident in the
second phase of the race when, however, a higher inter-individual
variability is present (Figure 1B). The resorption seems to be
strictly connected to this specific continuous and stressful exercise,
since it is not reported, after long periods of training, in top-level
athletes of other disciplines [12,34,35] However, when TRAP5b is
evaluated, its increase is evidenced, in top-level athletes, during the
most intense part of the season [13]. The balance between the
metabolic activities, operating within the bone remodeling unit,
could be represented by the ratio between BAP and TRAP5b.
During the race this ratio decreases, better demonstrating the
imbalance towards the resorption. This trend, due to osteoclasts
activation specifically marked by TRAP5b, which could enhance
OC decarboxylation, may represent a common trait of high-
demanding period in sportsmen, possibly inducing bone density
lowering in cyclists [14,36,37].
Bone resorption and osteoclasts activity are undoubtedly
enhanced in heavy cycling: the real impact of this finding and
(or) possible prompt recovery should be, however, further
investigated.
Adipokines have a direct and important role on bone and
cartilage metabolism [38,39]. The co-dependence of bone and
energy metabolism has never been studied in professional athletes.
Very few papers, describing chronic effects of exercise on
adipokines, are available and none of such studies were conducted
during strenuous long-lasting performances [20]. It is reported that
while strong acute exercise lowers leptin concentration, adiponec-
tin levels increased only after heavy long-lasting exercise through
the reduction of body mass and fat [20]. The study of adipokines
in professional cyclists is particularly interesting, because these
athletes are characterized by low BMI and very low fat percentage
[40].
Adiponectin increased throughout the race (Figure 3A), while
leptin dramatically decreased, showing a progressive narrowing in
standard deviation (Figure 3B). The two adipokines were inversely
related, definitely demonstrating the rising need of energy during
the race. This finding is also supported by the increase in the
relative Glu-OC concentration (Figure 2C), which could act by
stimulating the glucose utilization. Hinton and colleagues assessed
the increase of OC in 5 elite male cyclists during a 6-days bicycle
tour. They showed that OC increased of 300%, but this could be
due to the very low OC levels at baseline and/or to the evaluation
Figure 4. Modification of cortisol and testosterone concentra-
tions over the race. The Figure shows the trends of serum cortisol
(panel A) and serum testosterone (panel B) over the stage race.
** indicates a significant variation (p,0.01).
doi:10.1371/journal.pone.0042077.g004
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through only 5 days. Heavy increase in OC is likely due to the
stressful initial mechanical stimulation exerted on the bone; finally,
no information about the form of OC recognized by the assay
were reported [41]. The energy metabolism is potently enhanced
during the 3-weeks stage race: despite of the very high-caloric diet,
the tremendous need of energy, testified by the increase in the net
energy expenditure and the decrease in weight and, thus, in BMI
(Table 2), stimulates adipokines and related bone metabolites.
Moreover, adipokines trends were clearly related to the power
output and the energy expenditures.
Even if the only correlation among adipokines and bone OC
forms was found between adiponectin and Glu-OC, evident
correlations were found among Glu-OC, Glu-OC (%) and fat
mass (%) and BMI as well as between the adipokines and these
anthropometrical features. These findings suggest the presence of
a relation between undercarboxylated OC and the body
composition in line with previous reports. However, we speculate
the existence of another factor involved in their molecular link and
further studies must be addressed to uncover this marker. This link
is stressed by the relationship, even if fair, between the bony
metabolic index BAP/TRAP5b and levels of adiponectin and
leptin.
The decrease of cortisol (Figure 4A) was similar to that one
previously described during Vuelta [11]. Cortisol trend should be
linked to an exhausting mechanism, as suggested by the relation-
ship the indexes of metabolic effort. At the same time, a decrease
in endurance efforts and in adrenal sensitivity to adrenocortico-
tropic hormone stimulation, and a decreased hypothalamic-
pituitary axis sensitivity to cortisol negative feedback, may occur
[42]. Catabolic status, which is expected during a stage race, is
usually marked by an increase of cortisol. In our study, despite the
cortisol decrease, the catabolic status is, however, manifest and it is
demonstrated, at the adipose tissue level, by the leptin decrease
and, at the bony level, by the decrease in total OC (Figure 2) and
BAP/TRAP5b. Remarkably, positive relationships were found
among cortisol and leptin and among cortisol and total OC. A
possible explanation of this phenomenon could be hide in the
activation of the sympathetic nervous system, which is known to
affect the physiological homeostasis.
We did not observe significant decrease in testosterone
concentrations (Figure 4B), differently from a previous report
[11] where testosterone constantly decreased through the three
weeks of race of Vuelta, in18 cyclists belonging to two different
professional teams. Testosterone was significantly different be-
tween the two teams, but the decreasing trend was observed for
both [11]. This decrease was explained by body mass loss
accompanied by the reduction in fat mass; similarly, in our study,
we observed correlation between testosterone values and weight
loss, despite the decrease of testosterone levels was not significant.
Of note, our basal levels were lower than those reported before
Vuelta, while similar during the competition. A previous study
showed that testosterone values in professional cyclists, similar to
ours, were no different from those in controls, who had a higher
bone density [37]. We did not observe any correlation between
cortisol, testosterone, cortisol/testosterone and bone markers,
suggesting that the control of bone metabolism in cyclists is
uncoupled from these hormones.
The variations of testosterone and cortisol in cyclists, even
testifying a catabolic state, did not automatically lead to a decrease
in performance or to a state of overtraining, as demonstrated in
other sport disciplines [43]. Thus, further specific studies in
cycling, during stage races and also during a whole season, should
be necessary to better define hormonal modifications.
We finally want to point out that, to our knowledge, this is the
first study in which the pre-analytical management of the samples
has been accurately checked and, thus, we highlight a warning
about the previous researches concerning the pre-analytical phase,
mostly undescribed.
In conclusion, during a 3-weeks stage race, bone metabolism
parameters showed an unbalance towards resorption. A possible
relationship between bone and energy metabolisms is suggested by
the relative correlations among absolute and relative concentra-
tions trends of undercarboxylated OC, adipokines concentrations,
BMI, fat mass (%), power output and the derived energy
expenditure. The presence of this association, although a direct
link cannot be demonstrated, supports the evidence of a strict
involvement of bone in the regulation of the energy metabolism.
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